Home › Products › Oncology › Palbocib 125mg Capsule

Palbocib 125mg Capsule

Salt Composition: PALBOCICLIB

₹4028.00₹7600.00

Inclusive of all taxes

Palbocib 125mg Capsule

Categories: Oncology

Conditions: Anti Cancer

Product Introduction

Palbocib 125 mg is a targeted therapy containing the active constituent palbociclib. It belongs to the class of anticancer medications known as cyclin-dependent kinase inhibitors. This medicine is primarily prescribed for the treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, where cancer cells spread to other parts of the body. Palbocib is usually given in combination with other anticancer drugs to improve treatment outcomes.

The exact Palbocib 125 mg dosage depends on the patient's medical condition, tolerance, and physician's recommendation, and it should never be self-adjusted. Patients should ensure they obtain this medicine only from licensed pharmacies with a valid prescription.

When comparing Palbocib with Ibrance, both contain palbociclib as the active ingredient, but differences may exist in branding, pricing, and market availability. Doctors may also recommend Palbocib substitutes if needed, depending on the patient's health status and accessibility of the medicine. Palbocib 125 mg substitutes include Ibrance 125 mg, Palbace 125 mg, and Palkib 125 mg, all containing palbociclib as the active ingredient.

The Palbocib 125 mg composition works by blocking cyclin-dependent kinases, which play a crucial role in cancer cell growth and division. This mechanism helps slow down the progression of breast cancer. Patient experiences with Palbocib may vary, and responses to treatment differ individually.

Uses

Palbocib 125mg uses are Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.

How it works

Palbocib 125 mg works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading.

How to Use

Take Palbocib 125 mg exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.

Side Effects

Palbocib 125 mg side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Palbocib side effects are Serious: Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising) Lung inflammation (chest pain, dry cough, or difficulty breathing) Common: Tiredness Hair loss Dry skin, rash Infections Low blood cell counts Decreased of appetite Nausea, vomiting Diarrhea Swelling of lips and mouth Changes in taste Nose bleed Dry eye, blurred vision, increased tearing

References

  1. Pfizer Limited, Electronic medicines compendium (emc), [Revised on June 2021] [ Accessed on 26 Nov 2022], https://www.medicines.org.uk/emc/files/pil.4449.pdf
  2. Pfizer Labs, US Food and Drug Administration, [Revised on March 2017] [ Accessed on 26 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf
  3. Neha S Mangini et al; Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer; The Annals of Pharmacotherapy; Published on Nov 2015; Accessed on 26/11/2022; https://pubmed.ncbi.nlm.nih.gov/26324355/
  4. Palbace; Pfizer; Revised on Oct 2021; Accessed on 26/11/2022; https://labeling.pfizer.com/ShowLabeling.aspx?id=14029

Safety Advice

Pregnancy: unsafe It is not recommended to take Palbocib 125 mg during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.

Lungs: Consult your doctor It is not unknown whether Palbocib 125 mg can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.

Breastfeeding: unsafe It is not recommended to take Palbocib 125 mg while breastfeeding as it is not known whether it passes into the breast milk.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS